Anti-candidial activity of natural killer (NK) and lymphokine activated killer (LAK) lymphocytes in vitro

Immunobiology

Volumn 195, Issue 2, 1996, Pages 220-230

  Gülay, Zeynep ^a,b   Imir, Turgut ^a  

^a GAZI UNIVERSITY   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; INTERFERON ANTIBODY; MONOCLONAL ANTIBODY; RECOMBINANT INTERLEUKIN 2;

ADULT; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA; COLONY FORMATION; HUMAN; HUMAN CELL; LYMPHOKINE ACTIVATED KILLER CELL; MALE; MONONUCLEAR CELL; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL;

EID: 0029839748     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(96)80041-6     Document Type: Article

References (27)

1. HERBERMAN, R. B., and H. T. HOLDEN. 1978. Natural cell-mediated immunity. Adv. Cancer Res. 27: 305.
2. TIMONEN, T., and E. SAKSELA. 1980. Isolation of human natural killer cells by density gradient centrifugation. J. Immunol. Methods. 36: 285.
3. LOTZOVA, E., and C. A. SAVARY. 1993. Human natural killer cell development from bone marrow progenitors: analysis of phenotype, cytotoxicity and growth. Nat. Immunol. 12: 209.
4. KARRE, K., M. HANSSON, and R. KIESSLING. 1991. Multiple interactions at the natural killer workshop. Immunol. Today 12: 343.
5. BANKHURST, A. D., and T. IMIR. 1989. The mechanisms involved in the activation of human natural killer cells by staphylococcal enterotoxin B cell. Immunol. 122: 108.
6. SHEN, F., X.-L. XU, L. H. GRAF, and A. S. F. CHONG. 1995. CD-45 cross-linking stimulates IFN-γ production. J. Immunol. 154: 644.
7. D'ORAZIO, J. A., G. W. BURKE, and J. STEIN-STREILEIN. 1995. Staphylococcal enterotoxin B activates purified NK cells to secrete IFN-γ but requires T lymphocytes to augment NK cytotoxicity. J. Immunol. 154: 1014.
8. FERRINJ, S., A. CAMBIAGGI, S. SFORZINI, S. CANEVARI, D. MEZZANZANICA, M. I. COLNAGHI, and L. MORETTA. 1993. Use of anti-CD3 and anti-CD16 bispecific monoclonal antibodies for the targetting of T and NK cells against tumor cells. Cancer Detect. Prev. 17: 295.
9. RILEY, R. S., and E. J. MAHIN. 1989. Clinical application of flow cytometry. ASCP workshop # 9072, Washington DC, p. 35.
10. PERUSSIA, B. 1991. Lymphokine-activated killer cells, natural killer cells and cytokines. Curr. Opin. Immunol. 3: 49.
11. IMIR, T., D. L. GIBBS, W. L. SIBBITT Jr., and A. D. BANKHURST. 1985. Generation of natural killer cells and lymphokine-activated killer cells in human AB serum or fetal bovine serum. Clin. Immunol. and Immunopath. 36: 289.
12. AZZONI, L., I. ANEGON, B. CALABRETTA, and B. PERUSSIA. 1995. Ligand binding to FcγR induces c-myc dependent apoptosis in IL-2-stimulated NK cells. J. Immunol. 154: 491.
13. ORTALDO, J. R., and J. C. HISERODT. 1989. Mechanism of target cell killing by natural killer cells. Curr. Opin. Immunol. 2: 39.
14. PENARRUBIA, P., F. T. KOSTER, R. O. KELLEY, and A. D. BANKHURST. 1989. Antibacterial activity of human natural killer cells. J. Exp. Med. 169: 99.
15. LIPSCOMB, M. F., T. ALVARELLOS, G. G. TOEWS, and V. KUMAR. 1987. Role of natural killer cells in resistance to criptococcus neoformans in mice. Am. J. Pathol. 128: 354.
16. PETKUS, A. F., and L. L. BAUM. 1987. Natural killer cell inhibition of young spherules and endospores of Coccidioides Immitis. J. Immunol. 139: 3107.
17. BACCARINI, M., A. VECCHIARELLI, A. CASSONE, and F. BISTONI. 1985. Killing of yeast, germ tube and mycelial forms of C. albicans by murine effectors as measured by a radio label release micro assay. J. Gen. Microbiol. 131: 505.
18. RIPPON, J. W. 1988. Medical Mycology, 3rd ed. W. B. Saunders Company, Philadelphia, 566-575 pp.
19. VERSTEEG, R.. 1992. NK cells and T cells: mirror images? Immunol. Today 13: 244.
20. MILLER, M. F., T. G. MITCHELL, W. J. STORKUS, and J. R. DAWSON. 1990. Human natural killer cells do not inhibit growth of Cryptococcus neoformans in the absence of antibody. Infect. Immun. 58: 639.
21. HIDORE, M. R., N. NABAVI, C. W. REYNOLDS, P. A. HENKART, and J. W. MURPHY. 1990. Cytoplasmic components of natural killer cells limit the growth of Cryptococcus neoformans. J. Leuc. Biol. 48: 15.
22. LEVITZ, S. M., M. P. DUPONT, and E. H. SMAIL. 1994. Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans. Infect. Immun. 62: 194.
23. JIMENEZ, B. E., and J. W. MURPHY. 1984. In vitro effects of natural killer cells against Paracoccidioides brasiliensis yeast phase. Infect. Immun. 46: 552.
24. ZUNINO, S. J., and D. HUDIG. 1988. Interactions between human natural killer lymphocytes and yeast cells : human NK cells do not kill Candida albicans, although C. albicans block NK lysis of K562 cells. Infect. Immun. 56: 564.
25. BENO, D. W., and H. L. MATTHEWS. 1990. Growth inhibition of Candida albicans by interleukin-2 induced lymph node cells. Cell Immunol. 128: 89.
26. GRIMM, E. A., A. MAZUMDER, H. Z. ZHANG, and S. A. ROSENBERG. 1983. Lymphokine activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin-2 activated autologous human peripheral blood lymphocytes. J. Exp. Med. 155: 823.
27. + peripheral blood T lymphocytes contain lymphokine-activated killer cell precursors. Eur. J. Immunol. 19: 1037.